Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Blood Cancer J ; 3: e112, 2013 Apr 19.
Article in English | MEDLINE | ID: mdl-23599024

ABSTRACT

Monoclonal gammopathies (MGs) are hematological diseases characterized by high levels of a monoclonal immunoglobulin (Ig) or M-protein. Within this group are patients with more than one M-protein, referred to as double MGs (DMGs). The M-proteins in DMG patients may have different heavy chain (HC) isotypes that are associated with different light chains (LCs), or different HCs that are LC matched. In this study, we examined the clonal relatedness of the M-proteins in the latter type in a cohort of 14 DMG patients. By using PCR, we identified 7/14 DMG patients that expressed two Ig HC isotypes with identical Ig HC variable (IGHV), diversity (IGHD), joining (IGHJ), and complementarity determining region (HCDR3) sequences. Two additional DMG patients had two Ig transcripts using the same IGHV, IGHD and IGHJ genes but with slight differences in variable region or HCDR3 mutations. LC analysis confirmed that a single LC was expressed in 3/7 DMG patients with identical HC transcripts and in the two DMGs with highly similar transcripts. The PCR findings were confirmed by immunofluorescence for HC and LC expression. Clonally related HC-dissimilar/LC-matched DMGs may occur often and defines a new subtype of MG that may serve as a tool for studies of disease pathogenesis.

2.
Leukemia ; 26(10): 2286-96, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22460757

ABSTRACT

Multiple myeloma (MM) is preceded by the asymptomatic pre-malignant state, monoclonal gammopathy of undetermined significance (MGUS). Although MGUS patients may remain stable for years, they are at increased risk of progressing to MM. A better understanding of the relevant molecular changes underlying the transition from an asymptomatic to symptomatic disease state is urgently needed. Our studies show for the first time that the CD147 molecule (extracellular matrix metalloproteinase inducer) may be having an important biological role in MM. We first demonstrate that CD147 is overexpressed in MM plasma cells (PCs) vs normal and pre-malignant PCs. Next, functional studies revealed that the natural CD147 ligand, cyclophilin B, stimulates MM cell growth. Moreover, when MM patient PCs displaying bimodal CD147 expression were separated into CD147(bright) and CD147(dim) populations and analyzed for proliferation potential, we discovered that CD147(bright) PCs displayed significantly higher levels of cell proliferation than did CD147(dim) PCs. Lastly, CD147-silencing significantly attenuated MM cell proliferation. Taken together, these data suggest that the CD147 molecule has a key role in MM cell proliferation and may serve as an attractive target for reducing the proliferative compartment of this disease.


Subject(s)
Basigin/physiology , Cell Proliferation , Multiple Myeloma/pathology , Basigin/administration & dosage , Basigin/genetics , Cell Line, Tumor , Cyclophilins/pharmacology , DNA/biosynthesis , Gene Expression Regulation, Neoplastic , Humans , Multiple Myeloma/chemistry
3.
Leukemia ; 25(8): 1344-53, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21566653

ABSTRACT

DNA double-strand breaks (DSBs) are deleterious lesions that can lead to chromosomal anomalies, genomic instability and cancer. The histone protein H2AX has an important role in the DNA damage response (DDR) and the presence of phospho-H2AX (γH2AX) nuclear foci is the hallmark of DSBs. We hypothesize that ongoing DNA damage provides a mechanism by which chromosomal abnormalities and intratumor heterogeneity are acquired in malignant plasma cells (PCs) in patients with multiple myeloma (MM). Therefore, we assessed PCs from patients with the premalignant condition, monoclonal gammopathy of undetermined significance (MGUS) and MM, as well as human MM cell lines (HMCLs) for evidence of DSBs. γH2AX foci were detected in 2/5 MGUS samples, 37/40 MM samples and 6/6 HMCLs. Notably, the DSB response protein 53BP1 colocalized with γH2AX in both MM patient samples and HMCLs. Treatment with wortmannin decreased phosphorylation of H2AX and suggests phosphoinositide (PI) 3-kinases and/or PI3-kinase-like family members underlie the presence of γH2AX foci in MM cells. Taken together, these data imply that ongoing DNA damage intensifies across the disease spectrum of MGUS to MM and may provide a mechanism whereby clonal evolution occurs in the monoclonal gammopathies.


Subject(s)
DNA Damage , Histones/metabolism , Multiple Myeloma/genetics , Ataxia Telangiectasia Mutated Proteins , Cell Cycle , Cell Cycle Proteins/physiology , Cell Line, Tumor , Cell Nucleus/chemistry , Genes, p53 , Histones/analysis , Humans , Multiple Myeloma/metabolism , Mutation , Phosphatidylinositol 3-Kinases/physiology , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Protein Serine-Threonine Kinases/physiology
5.
Leukemia ; 20(11): 2034-40, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17024118

ABSTRACT

A specific role for increased level of expression of CKS1B, as a consequence of chromosome 1q21 copy number gain, has been postulated as both pathogenic, as well as a powerful clinical prognostic factor in multiple myeloma (MM). The purpose of this study is to determine the clinical associations and prognostic impact of copy number gain at chromosome 1q21 (with a bacteria artificial chromosome clone containing CKS1B) and CKS1B gene level of expression in MM. We studied the chromosome region 1q21 for copy number change in a cohort of myeloma patients treated by high-dose therapy with stem-cell rescue (HDT) (n = 159). A separate cohort of patients, treated by HDT was studied for CKS1B messenger RNA expression by gene expression profiling (n = 67). 1q21 gain was then correlated with clinical parameters and survival. Gain of 1q21 copy number was detected in about a third of MM and was associated with more proliferative disease and poor-risk cytogenetic categories such as t(4;14), and chromosome 13 deletion. Both 1q21 gain and increase gene expression level were significantly associated with reduced survival. However, neither is an independent prognostic marker in MM on multivariate Cox proportional hazard analysis.


Subject(s)
Carrier Proteins/genetics , Chromosomes, Human, Pair 1 , Cyclin-Dependent Kinases/genetics , In Situ Hybridization, Fluorescence , Multiple Myeloma/genetics , Multiple Myeloma/mortality , Biomarkers, Tumor/genetics , CDC2-CDC28 Kinases , Cell Division/genetics , Gene Dosage , Gene Expression Regulation, Neoplastic , Hematopoietic Stem Cell Transplantation , Humans , Multiple Myeloma/therapy , Prevalence , Prognosis , Proportional Hazards Models , RNA, Messenger/genetics , Risk Factors , Survival Rate
6.
Leukemia ; 15(6): 981-6, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11417487

ABSTRACT

Deletions of the long arm of chromosome 13 (13q-) are observed in patients with multiple myeloma (MM), are rarely observed in the monoclonal gammopathy of undetermined significance (MGUS) and have been associated with a worsened prognosis in MM. However, no minimally deleted region in the 13q arm has been defined at 13q, and consequently no tumor suppressor genes have yet been identified that are important for disease pathogenesis. We attempted to characterize these chromosome 13q deletions at the molecular cytogenetic level. We studied 351 newly diagnosed patients, entered into the E9486/E9487 clinical study of the Eastern Cooperative Oncology Group. Fluorescent in situ hybridization (FISH) combined with immune fluorescent detection (cIg-FISH) of clonal plasma cells (PC) and cytomorphology were used to analyze interphase, bone marrow (BM) cell, cytospin slides. We simultaneously used DNA probes for the following locus specific probes (LSI); LSI 13 (Rb) and D13S319, which hybridize to 13q14. We subsequently studied distal deletions using the D13S25 probe (13q14.3) and a subtelomeric probe (13qSTP) for the 13q-arm (D13S327) in 40 cases with documented LSI 13 (Rb)/D13S319 deletion and 40 without deletion of these loci. Of 325 evaluable patients, we found 13q deletions in 176 (54%) using LSI 13 (Rb) and D13S319 probes. Of 40 patients with LSI 13 (Rb)/D13S319 deletions, 34 (85%) had coexistent deletion of both D13S25/13qSTP. These results indicate that chromosome 13 deletions in MM involve loss of most if not all of the 13q arm perhaps even indicating monosomy. In six cases the 13qSTP signal was conserved, but D13S25 was lost indicating large interstitial deletions involving 13q14. In 39 of the 40 cases without LSI 13 (Rb)/D13S319 deletions, the normal pattern of two pairs of signals was observed for D13S25/13qSTP. Deletions involving 13q14 are very common in MM as detected by cIg-FISH. These deletions appear to predominantly involve loss of large segments of the 13q arm or monosomy 13, and only occasionally represent an interstitial deletion.


Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 13 , In Situ Hybridization, Fluorescence , Monosomy , Multiple Myeloma/genetics , Sequence Deletion , Adult , Aged , Aged, 80 and over , Bone Marrow/pathology , Chromosomes, Human, Pair 13/ultrastructure , DNA Probes , Female , Genetic Markers , Humans , Interphase , Male , Middle Aged , Prognosis
7.
Chest ; 119(2): 470-7, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11171725

ABSTRACT

STUDY OBJECTIVES: To determine if transcatheter embolotherapy is safe and effective for the treatment of pulmonary arteriovenous malformations during pregnancy. DESIGN: Prospective study. SETTING: Specialized hereditary hemorrhagic telangiectasia centers at Yale University School of Medicine and St. Michael's Hospital, University of Toronto. PATIENTS: Seven pregnant women (age range, 24 to 34 years; gestational age range, 16 to 36 weeks) undergoing transcatheter embolotherapy. INTERVENTIONS: Transcatheter embolotherapy in all patients. MEASUREMENTS AND RESULTS: Thirteen pulmonary arteriovenous malformations in seven patients were embolized with detachable silicone balloons and/or stainless steel coils without incident. The estimated fetal radiation dose ranged from < 50 to 220 mrad. No complications of pulmonary arteriovenous malformations occurred in any of the patients after transcatheter embolotherapy. The mothers went on to deliver healthy babies in all cases. CONCLUSIONS: Transcatheter embolotherapy of maternal pulmonary arteriovenous malformations performed by an experienced radiologist appears to be safe and effective after 16 weeks of gestational age.


Subject(s)
Arteriovenous Malformations/therapy , Embolization, Therapeutic , Pregnancy Complications, Cardiovascular/therapy , Pulmonary Artery/abnormalities , Pulmonary Veins/abnormalities , Adult , Female , Humans , Pregnancy
8.
J Vasc Interv Radiol ; 11(10): 1285-95, 2000.
Article in English | MEDLINE | ID: mdl-11099238

ABSTRACT

PURPOSE: To assess the long-term efficacy of embolotherapy in combination with surgery for management of symptomatic high-flow arteriovenous malformations (HFAVMs) of the lower and upper extremities. MATERIALS AND METHODS: Twenty consecutive patients with symptomatic high-flow lower extremity AVMs (LE-AVMs; n = 9) and upper extremity AVMs (UE-AVMs; n = 11) were treated from 1982 to 1999. All nine patients with LE-AVM had pain and seven had ulceration of the skin. All 11 patients with UE-AVM had debilitating pain, seven had weakness of the affected hand, and two had bony erosion. Embolization of the nidus beneath the site of maximum pain or ulceration was performed percutaneously from the femoral artery through coaxially placed microcatheters (n = 18) or surgical cutdown (n = 2). Cyanoacrylate (isobutyl or n-butyl) diluted with iophendylate or ethiodized oil was used in 19 of 20 patients. RESULTS: Follow-up was completed in eight of nine patients with LE-AVM (mean, 8.6 y) and nine of 11 patients with UE-AVM (mean, 7.4 y) after treatment. One patient with localized LE-AVM was functioning well 13 years after embolotherapy and another was functioning well 16 years after undergoing three embolotherapy procedures and two skin grafts. Five of nine patients with LE-AVM required below-the-knee (n = 4) or above-the-knee (n = 1) amputation 1-6 years after technically and clinically successful embolotherapy. All three trifurcation arteries were diffusely involved in HFAVM in patients requiring amputation. Healing of the two amputation sites, involved by AVM at the knee, was excellent after preoperative geniculate artery embolotherapy. All 11 patients with UE-AVM experienced marked symptomatic improvement; seven after embolotherapy alone and the other four after resection of AVM. One complication of digital spasm was reversed by administration of nerve blocks. CONCLUSIONS: LE-AVM with diffuse involvement of all three trifurcation arteries ultimately required amputation because of recurrence of symptoms after technically and clinically successful embolotherapy. Cyanoacrylate embolotherapy alone or in combination with surgical resection of the AVM provided excellent long-term palliation in patients with UE-AVM.


Subject(s)
Arteriovenous Malformations/therapy , Embolization, Therapeutic , Adolescent , Adult , Amputation, Surgical , Arm/blood supply , Arteriovenous Malformations/surgery , Combined Modality Therapy , Contrast Media/administration & dosage , Cyanoacrylates/administration & dosage , Female , Follow-Up Studies , Humans , Iophendylate/administration & dosage , Leg/blood supply , Male , Middle Aged , Recurrence , Treatment Outcome
9.
N Engl J Med ; 343(13): 931-6, 2000 Sep 28.
Article in English | MEDLINE | ID: mdl-11006369

ABSTRACT

BACKGROUND: Hereditary hemorrhagic telangiectasia, or Rendu-Osler-Weber disease, is an autosomal dominant disorder characterized by angiodysplastic lesions (telangiectases and arteriovenous malformations) that affect many organs. Liver involvement in patients with this disease has not been fully characterized. METHODS: We studied the clinical findings and results of hemodynamic, angiographic, and imaging studies in 19 patients with hereditary hemorrhagic telangiectasia and symptomatic liver involvement. RESULTS: We evaluated 14 women and 5 men who ranged in age from 34 to 74 years. All but one of the patients had a hyperdynamic circulation (cardiac index, 4.2 to 7.3 liters per minute per square meter of body-surface area). In eight patients, the clinical findings were consistent with the presence of high-output heart failure. The cardiac index and pulmonary-capillary wedge pressure were elevated in the six patients in whom these measurements were performed. After a median period of 24 months, the condition of three of the eight patients had improved, four were in stable condition with medical therapy, and one had died. Six patients had manifestations of portal hypertension such as ascites or variceal bleeding. The hepatic sinusoidal pressure was elevated in the four patients in whom it was measured. After a median period of 19 months, the condition of two of the six patients had improved, and the other four had died. Five patients had manifestations of biliary disease, such as an elevated alkaline phosphatase level and abnormalities on bile duct imaging. After a median period of 30 months, the condition of two of the five had improved, the condition of one was unchanged, heart failure had developed in one, and one had died after an unsuccessful attempt at liver transplantation. CONCLUSIONS: In patients with hereditary hemorrhagic telangiectasia and symptomatic liver-involvement, the typical clinical presentations include high-output heart failure, portal hypertension, and biliary disease.


Subject(s)
Liver Diseases/etiology , Telangiectasia, Hereditary Hemorrhagic/complications , Adult , Aged , Biliary Tract Diseases/etiology , Cardiac Output, High/etiology , Female , Heart Failure/etiology , Humans , Hypertension, Portal/etiology , Liver/pathology , Liver Diseases/pathology , Male , Middle Aged , Telangiectasia, Hereditary Hemorrhagic/mortality
10.
J Toxicol Clin Toxicol ; 38(4): 421-8, 2000.
Article in English | MEDLINE | ID: mdl-10930059

ABSTRACT

STUDY OBJECTIVE: To evaluate the potential utility of sodium bicarbonate in an established model of acute propranolol toxicity. METHODS: Two minutes after the completion of a propranolol infusion (10 mg/kg), a bolus of 1.5 mEq/kg of sodium bicarbonate solution (1 mEq/mL) followed by an infusion of 1.5 mEq/kg over the next 26 minutes (n = 6) or an equivalent timing and volume of 5% dextrose solution (n = 6) was administered in each dog. Targeted cardiovascular parameters included heart rate, mean arterial pressure, left ventricular dP/dtmax, and QRS interval. RESULTS: Propranolol infusion significantly depressed heart rate (p < 0.0001), mean arterial pressure (p < 0.0001), dP/dtmax (p < 0.0001) and prolonged the QRS interval (p < 0.0001). Sodium bicarbonate failed to significantly improve these targeted parameters when compared to control animals. CONCLUSION: In this canine model of propranolol toxicity, intravenous sodium bicarbonate appears to be an ineffective single therapy. Furthermore, these results may suggest a different mechanism of sodium channel blockade for propanolol than that of type IA antiarrhythmic agents.


Subject(s)
Cardiovascular Diseases/chemically induced , Cardiovascular Diseases/drug therapy , Propranolol/toxicity , Sodium Bicarbonate/administration & dosage , Animals , Bicarbonates/blood , Blood Pressure/drug effects , Disease Models, Animal , Dogs , Electrocardiography , Heart Conduction System/drug effects , Heart Rate/drug effects , Infusions, Intravenous , Poisoning/drug therapy , Propranolol/administration & dosage , Sodium/blood , Treatment Outcome , Ventricular Function, Left/drug effects
11.
Radiol Clin North Am ; 38(2): 425-48, ix, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10765399

ABSTRACT

This two-part article first discusses the role of bronchial artery transcatheter embolotherapy in the management of patients with hemoptysis. Following this discussion, the authors review pulmonary arteriovenous malformations, their embolization, follow-up protocols, and outcome criteria as currently practiced at the authors' Vascular Malformation Center.


Subject(s)
Bronchi/blood supply , Embolization, Therapeutic , Pulmonary Circulation , Angiography , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/therapy , Bronchography , Contraindications , Embolization, Therapeutic/adverse effects , Embolization, Therapeutic/instrumentation , Embolization, Therapeutic/methods , Humans , Pulmonary Artery/abnormalities , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/therapy , Pulmonary Veins/abnormalities , Treatment Outcome
12.
Ann Rheum Dis ; 53(11): 729-34, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7529985

ABSTRACT

OBJECTIVE: To determine if expression of CD44, the principal receptor for hyaluronan, was altered in rheumatoid (RA) synovium and cultured rheumatoid synovial fibroblasts. METHODS: Synovium was obtained from normal adult human joints (n = 4) and from joints of patients with RA (n = 5). Specific monoclonal antibodies to CD44 were used in immunofluorescence of whole synovium and cultured synovial fibroblasts and in quantitative Western blotting and ELISA of CD44 in cultured synovial fibroblasts. RESULTS: CD44 was restricted to the lining layer in normal synovium but present, in reduced concentrations, throughout rheumatoid synovium. Cultured rheumatoid cells were 19% larger in area and showed far fewer and less extensive CD44-positive cytoplasmic extensions, together with reduced staining intensity compared with normal. Quantitative Western blotting normalised for cell protein showed a 75% reduction (normal = 1754 (835), rheumatoid = 409 (84) mean (SD) arbitrary units) in the amount of CD44 in rheumatoid cells compared with normal, and enzyme linked immunosorbent assay (ELISA) of cultured cell monolayers normalised for cell number indicated a 29% reduction (normal = 0.707 (0.110), rheumatoid = 0.504 (0.103), mean (SD) optical density at 405 nm). CONCLUSIONS: Rheumatoid synovial cells showed altered morphology and reduced CD44 expression compared with normal cells. CD44, by means of modulated associations with the cytoskeleton, may be involved in cell shape change.


Subject(s)
Arthritis, Rheumatoid/immunology , Carrier Proteins/analysis , Receptors, Cell Surface/analysis , Receptors, Lymphocyte Homing/analysis , Synovial Membrane/immunology , Aged , Antibodies, Monoclonal , Arthritis, Rheumatoid/pathology , Blotting, Western , Cells, Cultured , Fibroblasts/immunology , Fibroblasts/pathology , Fluorescent Antibody Technique , Humans , Hyaluronan Receptors , Middle Aged , Synovial Membrane/pathology
13.
J Anat ; 185 ( Pt 2): 355-67, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7525525

ABSTRACT

During fetal development, cavitation occurs within the primitive skeleton along planes destined to become the articular surfaces of synovial joints. A histochemical study of human fetal limbs was undertaken to identify the cell types involved in this cavitation and the possible role of interactions between cells and extracellular matrix. Cryostat sections were stained with antibodies to CD68, factor VIII related antigen, prolyl hydroxylase, beta 1 integrin, VCAM-1, proliferating cell nuclear antigen, chondroitin-4 sulphate, chondroitin-6-sulphate, hyaluronan synthase and CD44. Similar sections were reacted for uridine diphosphoglucose dehydrogenase (UDPGD) and acid phosphatase activity. Hyaluronan was demonstrated using an aggrecan core protein hyaluronan binding region probe. Macrophages were present prior to cavitation in the periphery of joint interzones but not at the presumptive joint line in the central interzone. Fibroblastic cells were present throughout. Absence of local VCAM-1 expression indicated that cavitation was temporally distinct from full fibroblast-like synoviocyte differentiation. CD44 was expressed by interzone cells at all stages. Staining for hyaluronan and hyaluronan synthase, but not chondroitin sulphates was present in the interzone before and at the time of cavitation. UDPGD activity was increased in a narrow band of cells at the presumptive joint line prior to cavitation. These findings suggest that joint cavitation is dependent on the behaviour of fibroblastic cells and/or adjacent chondrocytes, rather than macrophages. Since UDPGD activity is involved in hyaluronan synthesis, it is proposed that joint cavitation is facilitated by a rise in local hyaluronan concentration in an area of tissue where cohesion is dependent on the interaction between cellular CD44 and extracellular hyaluronan. As proposed by Toole et al. (1984) such a local rise in hyaluronan concentration may lead to a switch from intercellular cohesion to dissociation, leading to tissue cavitation.


Subject(s)
Carrier Proteins/physiology , Glycosyltransferases , Hyaluronic Acid/physiology , Joints/embryology , Membrane Proteins , Receptors, Cell Surface/physiology , Receptors, Lymphocyte Homing/physiology , Transferases , Xenopus Proteins , Ankle Joint/embryology , Ankle Joint/metabolism , Carrier Proteins/analysis , Cell Division , Chondroitin Sulfates/metabolism , Elbow Joint/embryology , Elbow Joint/metabolism , Gestational Age , Glucuronosyltransferase/metabolism , Hip Joint/embryology , Hip Joint/metabolism , Humans , Hyaluronan Receptors , Hyaluronan Synthases , Hyaluronic Acid/analysis , Immunohistochemistry , Joints/metabolism , Knee Joint/embryology , Knee Joint/metabolism , Receptors, Cell Surface/analysis , Receptors, Lymphocyte Homing/analysis , Shoulder Joint/embryology , Shoulder Joint/metabolism , Synovial Membrane/embryology , Synovial Membrane/metabolism , Uridine Diphosphate Glucose Dehydrogenase/metabolism , Wrist Joint/embryology , Wrist Joint/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...